RUBICON RESEARCH
Midcap | BSE
Sector
Index
Here's the live share price of Rubicon Research along with daily highs, lows, percentage changes and volume trends, and, all financial information.
8.29₹ 134.20
As on Aug 17, 2026, 01:54 PM IST
Source: Dion Global
Rubicon Research Price Performance
Today's LowToday's High
₹1,630.00₹1,800.00
₹1,752.15
52 Weeks' Low52 Weeks' High
₹571.00₹1,686.45
₹1,752.15
Open Price
₹1,701.80
Prev. Close
₹1,617.95
Volume
1,33,787
Source: Dion Global
Rubicon Research Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Rubicon Research | 14.57 | 22.71 | 85.11 | 124.52 | 183.97 | 41.51 | 23.16 |
| Sun Pharmaceutical Industries | -2.57 | -2.74 | 1.01 | 11.72 | 16.33 | 18.41 | 19.45 |
| Divi's Laboratories | 3.11 | 16.75 | 25.79 | 38.21 | 37.93 | 31.84 | 11.64 |
| Torrent Pharmaceuticals | -1.49 | -2.79 | 10.71 | 14.49 | 33.53 | 34.90 | 26.98 |
| Cipla | -2.94 | -0.64 | -0.20 | 5.38 | -8.67 | 4.77 | 9.97 |
| Zydus Lifesciences | 1.69 | -1.77 | 12.14 | 24.62 | 14.95 | 19.94 | 16.35 |
| Lupin | -4.88 | -9.91 | -1.28 | 1.09 | 13.98 | 26.35 | 18.34 |
| Dr. Reddy's Laboratories | 1.88 | -2.91 | -10.69 | -5.93 | -5.53 | 0.57 | 5.07 |
| Mankind Pharma | -1.92 | -6.06 | -4.46 | 14.90 | -3.15 | 9.55 | 10.91 |
| Laurus Labs | -3.03 | 15.69 | 35.82 | 77.61 | 107.88 | 66.39 | 21.14 |
| Aurobindo Pharma | -2.04 | 4.90 | 7.66 | 37.32 | 49.28 | 23.05 | 17.12 |
| Biocon | -4.26 | -5.28 | -4.27 | 8.27 | 13.04 | 17.01 | 2.32 |
| Glenmark Pharmaceuticals | 1.62 | 1.26 | -0.04 | 14.41 | 17.71 | 42.75 | 32.43 |
| Alkem Laboratories | -3.19 | -3.82 | -0.62 | -0.53 | 1.91 | 12.97 | 7.97 |
| Abbott India | -3.69 | -3.18 | -4.22 | 1.64 | -18.00 | 3.92 | 7.14 |
| Anthem Biosciences | 6.18 | 18.81 | 13.95 | 29.69 | 11.50 | 6.87 | 4.07 |
| Ipca Laboratories | 8.52 | 0.38 | 17.38 | 25.65 | 36.12 | 28.49 | 9.33 |
| Gland Pharma | 10.52 | 16.65 | 53.93 | 58.85 | 45.77 | 22.97 | -6.99 |
| Ajanta Pharma | 6.19 | 7.27 | 16.67 | 25.88 | 37.71 | 27.83 | 19.53 |
| GlaxoSmithKline Pharmaceuticals | 4.46 | 8.97 | 11.02 | 4.24 | -2.90 | 24.17 | 11.01 |
Source: Dion Global
Over the last one year, Rubicon Research has gained 183.97% compared to peers like Sun Pharmaceutical Industries (16.33%), Divi's Laboratories (37.93%), Torrent Pharmaceuticals (33.53%). From a 5 year perspective, Rubicon Research has outperformed peers relative to Sun Pharmaceutical Industries (19.45%) and Divi's Laboratories (11.64%).
Rubicon Research Financials
Source: Dion Global
Rubicon Research Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,628.36 | 1,615.9 |
| 10 | 1,582.46 | 1,591.11 |
| 20 | 1,549.16 | 1,547.94 |
| 50 | 1,433.44 | 1,420.34 |
| 100 | 1,180.11 | 1,242.63 |
| 200 | 936.66 | 946.24 |
Source: Dion Global
Rubicon Research Share Holding Pattern
In the latest quarter, Rubicon Research saw a drop in promoter holding to 59.76%, while DII stake decreased to 9.43%, FII holding fell to 7.52%, and public shareholding moved up to 23.29% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Rubicon Research Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 37,78,406 | 0.81 | 563.36 | |
| 5,18,073 | 4.56 | 77.24 | |
| 1,21,051 | 1.21 | 18.05 | |
| 50,000 | 0.08 | 7.46 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Rubicon Research Corporate Actions
Date Time | Announcement |
|---|---|
| Aug 15, 2026, 03:37 AM IST IST | Rubicon Research - Audio Recording Of Earnings Conference Call For The Quarter Ended 30Th June, 2026. |
| Aug 14, 2026, 10:56 PM IST IST | Rubicon Research - Announcement under Regulation 30 (LODR)-Monitoring Agency Report |
| Aug 14, 2026, 10:50 PM IST IST | Rubicon Research - Announcement under Regulation 30 (LODR)-Change in Management |
| Aug 14, 2026, 10:37 PM IST IST | Rubicon Research - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Aug 14, 2026, 10:30 PM IST IST | Rubicon Research - Board Meeting Outcome for Unaudited Financials Results For Quarter Ended June 30, 2026 |
Source: Dion Global
About Rubicon Research
Rubicon Research Ltd. is a Public Limited Listed company incorporated on 06/05/1999 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is U73100MH1999PLC119744 and registration number is 119744. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 1306.08 Cr. and Equity Capital is Rs. 16.51 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- AddressMedOne House, B-75, Road No. 33, Wagle Estate, Thane Maharashtra 400604
- Contact
Source: Dion Global
Management
- Ms. Pratibha PilgaonkarManaging Director
- Mr. Parag Suganchand SanchetiExecutive Director & CEO
- Mr. Venkat ChangavalliChairperson & Independent Director
- Mr. Varun TalukdarNon Executive Director
- Mr. Shantanu RastogiNon Executive Director
- Mr. Anand AgarwalNon Executive Director
- Mr. Kumarapuram Gopalakrishnan AnanthakrishnanIndependent Director
- Mr. Milind Anil PatilIndependent Director
FAQs on Rubicon Research Share Price
What is the share price of Rubicon Research?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Rubicon Research is ₹1,752.15 as on Aug 17, 2026.
What kind of stock is Rubicon Research?
The Rubicon Research is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of Rubicon Research?
The market cap of Rubicon Research is ₹29,486.20 Cr as on Aug 17, 2026.
What are today's High and Low prices of Rubicon Research?
Today’s highest and lowest price of Rubicon Research are ₹1,800.00 and ₹1,630.00.
What are the 52 Week High and 52 Week Low of Rubicon Research?
The 52-week high/low is the highest and lowest price at which Rubicon Research stock has traded in the past 52-week or nearly a year. The 52-week high of Rubicon Research is ₹1,686.45 and 52-week low of Rubicon Research is ₹571.00 as on Aug 17, 2026.
How has the Rubicon Research performed historically in terms of returns?
The Rubicon Research has shown returns of 9.98% over the past day, 22.55% for the past month, 84.86% over 3 months, 183.59% over 1 year, 41.55% across 3 years, and 23.18% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Rubicon Research?
P/E ratio of and PB ratio of Rubicon Research are 102.31 and 22.88 on Aug 17, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global
✕